Skip to main content

Table 3 Symptoms of reported patients at diagnosis by fibrosis stage, for patients with a current fibrosis score

From: Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database

Symptoms at diagnosis

Fatigue

Weight gain

Asymptomatic

General weakness

Hepatomegaly

Right upper quadrant pain

Sleep Apnea

Signs of liver disease

Weight loss

Other

Total (n = 2,312)

40%

37%

27%

25%

20%

18%

17%

9%

2%

2%

F0 (n = 189)

27%

33%

45%

10%

4%

5%

11%

2%

2%

2%

F1 (n = 576)

41%

35%

30%

25%

16%

13%

16%

5%

1%

2%

F2 (n = 843)

43%

37%

30%

28%

22%

17%

17%

4%

2%

1%

F3 (n = 486)

41%

43%

18%

28%

28%

24%

20%

8%

3%

3%

F4 (n = 218)

38%

30%

10%

25%

26%

28%

14%

44%

6%

6%

  1. Fibrosis stages range from none (F0) to cirrhosis (F4). Patients with unknown fibrosis stage not shown (n = 54)
  2. Source: Ipsos NASH Therapy Monitor (NASH-treating physicians in US reporting on patients seen in consultation in 2016 [n = 174] and 2017 [n = 164]; data collected online). Data © Ipsos 2022, all rights reserved